Longboard Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Longboard Pharmaceuticals, Inc.

Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing transformative medicines for neurological diseases. The company's lead product candidate is LP352, which is in a Phase 1b/2a clinical trial for the treatme…

Biotechnology
US, La Jolla [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group

Peers Performance

A quick analysis that compared Longboard Pharmaceuticals, Inc. (LBPH) to it's peer group.

Peer Group
Loading...
End of LBPH's Analysis
CIK: 1832168 CUSIP: 54300N103 ISIN: US54300N1037 LEI: - UEI: -
Secondary Listings
LBPH has no secondary listings inside our databases.